1. Home
  2. REGCO vs DAWN Comparison

REGCO vs DAWN Comparison

Compare REGCO & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regency Centers Corporation 5.875% Series B Cumulative Redeemable Preferred Stock

REGCO

Regency Centers Corporation 5.875% Series B Cumulative Redeemable Preferred Stock

N/A

Current Price

$22.64

Market Cap

0.0

Sector

N/A

ML Signal

N/A

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$8.40

Market Cap

624.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REGCO
DAWN
Founded
N/A
2018
Country
United States
United States
Employees
500
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
624.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
REGCO
DAWN
Price
$22.64
$8.40
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$26.56
AVG Volume (30 Days)
N/A
2.6M
Earning Date
N/A
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$133,672,000.00
Revenue This Year
N/A
$15.51
Revenue Next Year
N/A
$49.99
P/E Ratio
N/A
N/A
Revenue Growth
N/A
31.11
52 Week Low
N/A
$5.64
52 Week High
N/A
$13.53

Technical Indicators

Market Signals
Indicator
REGCO
DAWN
Relative Strength Index (RSI) 43.10 48.66
Support Level $22.49 $7.90
Resistance Level $22.78 $8.67
Average True Range (ATR) 0.16 0.52
MACD 0.01 -0.09
Stochastic Oscillator 29.38 26.54

Price Performance

Historical Comparison
REGCO
DAWN

About REGCO Regency Centers Corporation 5.875% Series B Cumulative Redeemable Preferred Stock

Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 483 properties, which includes over 57 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

Share on Social Networks: